Search results for "Anticoagulation"


 
Results 41 - 50 of about 593 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Negative trials of prone positioning, antiplatelet therapy for COVID-19

Telling inpatients to lay on their stomachs did not significantly improve outcomes, one study found, while others offered some mixed results on the effects of aspirin and P2Y12 inhibitors. Additional research showed that a commonly used triage score doesn't work for COVID-19 and that hospitalists' worry about catching the virus impaired their well-being.
https://acphospitalist.acponline.org/archives/2022/03/30/free/negative-trials-of-prone-positioning-antiplatelet-therapy-for-covid-19.htm
30 Mar 2022

Advance care planning assessed, therapeutic heparin debated in recent COVID-19 articles

Along with an analysis of the pre-existing conditions of patients who died of COVID-19 and a point/counterpoint on use of heparin in ward patients, the latest inpatient COVID-19 research included negative trials of losartan and a potential monoclonal antibody.
https://acphospitalist.acponline.org/archives/2022/03/23/free/advance-care-planning-assessed-therapeutic-heparin-debated-in-recent-covid-19-articles.htm
23 Mar 2022

DOACs better than heparin for periop thromboprophylaxis, review finds

The systematic review and network meta-analysis found lower rates of symptomatic venous thromboembolism in surgical patients given direct oral anticoagulants (DOACs) versus the standard dose of low-molecular-weight heparin, without a significant increase in bleeding.
https://acphospitalist.acponline.org/archives/2022/03/16/doacs-better-than-heparin-for-periop-thromboprophylaxis.htm
16 Mar 2022

Infected femoral closure device after cardiac catheterization

A patient presented with cellulitis at a vascular access site 10 days after undergoing cardiac catheterization.
https://acphospitalist.acponline.org/archives/2022/03/09/free/brief-case-infected-femoral-closure-device.htm
9 Mar 2022

Pulmonary embolism

For optimal documentation, coding, and reimbursement, the location or type of pulmonary embolism needs to be clearly identified.
https://acphospitalist.acponline.org/archives/2022/02/23/coding-corner-pulmonary-embolism.htm
23 Feb 2022

Diagnosing pulmonary embolism

Experts offer advice on how to apply the wide variety of available validated scores and algorithms, but also clinical judgment, to find pulmonary embolisms without excessive testing.
https://acphospitalist.acponline.org/archives/2022/02/23/free/diagnosing-pulmonary-embolism.htm
23 Feb 2022

Rule developed for starting DOACs after stroke in patients with atrial fibrillation

Using a “1-2-3-4-day rule” to choose when to start direct-acting oral anticoagulants (DOACs) based on stroke severity appeared to decrease risk for recurrent stroke or systemic embolism without increasing bleeding risk.
https://acphospitalist.acponline.org/archives/2022/02/09/rule-developed-for-starting-doacs-after-stroke-in-patients-with-atrial-fibrillation.htm
9 Feb 2022

Adding P2Y12 inhibitor to heparin offered no benefit in non-critically ill COVID-19 inpatients

An open-label randomized trial at 60 hospitals in four countries found no increase in organ support-free days in patients who received a therapeutic dose of heparin plus a P2Y12 inhibitor versus heparin alone.
https://acphospitalist.acponline.org/archives/2022/01/19/free/adding-P2Y12-inhibitor-to-heparin-offered-no-benefit.htm
19 Jan 2022

NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant

The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/free/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022

COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects

The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next